Security · featured owners
CRNX Crinetics Pharmaceuticals In
Health Care COM Equity as of 2026 Q2 among managers we track
- 1 Owner
- Max 1.6%
- $336M
- 1 add
CRNX (Crinetics Pharmaceuticals In) is held in 1 featured 13F book as of 2026 Q2. Farallon Capital Management is the largest tracked holder by portfolio weight (1.6%). Figures are as-filed 13F, not free float.
Who owns this now
Largest portfolio weights among featured holders · max 1.6% (Farallon Capital Management) · not free-float ownership
holders
sorted by value · long equity only · current book 2026 Q2 · open a manager for their book
| history | |||||
|---|---|---|---|---|---|
| Farallon Capital Management 2026 Q2 | 1.6% | Add +7.8% | 8,989,098 | $336M | history |
ownership over time
filing count by report period · click a bar for that quarter’s holders